1. Home
  2. PDX vs BHVN Comparison

PDX vs BHVN Comparison

Compare PDX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PDX

PIMCO Dynamic Income Strategy Fund of Beneficial Interest

HOLD

Current Price

$21.43

Market Cap

931.2M

Sector

Finance

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.10

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDX
BHVN
Founded
2019
2013
Country
NY
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
931.2M
1.1B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
PDX
BHVN
Price
$21.43
$11.10
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
$29.79
AVG Volume (30 Days)
N/A
3.1M
Earning Date
01-01-0001
11-10-2025
Dividend Yield
4.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,147.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.52
$7.48
52 Week High
$21.05
$44.28

Technical Indicators

Market Signals
Indicator
PDX
BHVN
Relative Strength Index (RSI) 50.49 53.32
Support Level $21.39 $8.50
Resistance Level $22.15 $11.80
Average True Range (ATR) 0.34 0.91
MACD 0.07 0.08
Stochastic Oscillator 56.35 81.83

Price Performance

Historical Comparison
PDX
BHVN

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: